Mink Brook Asset Management LLC Ocuphire Pharma, Inc. Transaction History
Mink Brook Asset Management LLC
- $115 Billion
- Q2 2025
A detailed history of Mink Brook Asset Management LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Mink Brook Asset Management LLC holds 1,197,616 shares of OCUP stock, worth $1.17 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
1,197,616
Previous 810,080
47.84%
Holding current value
$1.17 Million
Previous $795 Million
41.86%
% of portfolio
0.98%
Previous 0.84%
Shares
2 transactions
Others Institutions Holding OCUP
# of Institutions
50Shares Held
17.6MCall Options Held
19KPut Options Held
0-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.19% of portfolio
-
Bios Capital Management, LP Fort Worth, TX3.68MShares$3.61 Million4.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.35MShares$3.28 Million0.14% of portfolio
-
Opaleye Management Inc. Boston, MA1.22MShares$1.2 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...